Morepen Laboratories Limited (BOM:500288)
India · Delayed Price · Currency is INR 92.00
-4.80 (-4.96%)
At close: Nov 6, 2026
Morepen Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 50,412 | 18,521 | 26,220 | 21,500 | 13,127 | 17,488 | |
Market Cap Growth | 90.83% | -29.36% | 21.95% | 63.79% | -24.94% | 20.93% |
Enterprise Value | 50,940 | 19,304 | 24,690 | 21,194 | 12,944 | 17,090 |
Last Close Price | 92.00 | 33.74 | 47.57 | 41.81 | 25.53 | 36.38 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 26.67 | 19.52 | 22.22 | 22.36 | 33.94 | 17.20 |
PS Ratio | 2.21 | 1.03 | 1.45 | 1.27 | 0.92 | 1.12 |
PB Ratio | 3.65 | 1.49 | 2.21 | 2.54 | 1.75 | 3.03 |
P/TBV Ratio | 4.07 | 1.64 | 2.60 | 2.86 | 2.01 | 3.69 |
P/FCF Ratio | 145.99 | - | - | 1078.33 | - | - |
P/OCF Ratio | 34.94 | 56.74 | 81.79 | 29.30 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.23 | 1.07 | 1.36 | 1.25 | 0.91 | 1.10 |
EV/EBITDA Ratio | 18.77 | 17.54 | 15.22 | 13.36 | 15.41 | 11.73 |
EV/EBIT Ratio | 21.06 | 21.64 | 17.02 | 16.93 | 23.08 | 14.48 |
EV/FCF Ratio | 147.52 | - | - | 1063.01 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.23 | 0.17 | 0.09 | 0.03 | 0.03 | 0.23 |
Debt / EBITDA Ratio | 1.19 | 1.72 | 0.60 | 0.18 | 0.30 | 0.91 |
Debt / FCF Ratio | 9.35 | - | - | 14.55 | - | - |
Net Debt / Equity Ratio | 0.04 | 0.12 | 0 | 0.01 | 0.01 | 0.20 |
Net Debt / EBITDA Ratio | 0.20 | 1.40 | 0.00 | 0.08 | 0.04 | 0.81 |
Net Debt / FCF Ratio | 1.51 | -2.91 | 0.00 | 6.05 | -0.03 | -1.11 |
Asset Turnover | 1.13 | 0.97 | 1.18 | 1.41 | 1.30 | 1.61 |
Inventory Turnover | 4.48 | 4.02 | 4.32 | 4.55 | 3.86 | 4.70 |
Quick Ratio | 0.85 | 0.80 | 0.86 | 0.87 | 0.90 | 0.59 |
Current Ratio | 1.98 | 2.37 | 2.32 | 2.21 | 2.35 | 1.61 |
Return on Equity (ROE) | 14.61% | 7.86% | 11.60% | 12.08% | 5.81% | 20.29% |
Return on Assets (ROA) | 7.48% | 3.00% | 5.91% | 6.51% | 3.21% | 7.65% |
Return on Invested Capital (ROIC) | 13.05% | 5.50% | 10.79% | 11.06% | 5.36% | 15.59% |
Return on Capital Employed (ROCE) | 15.30% | 6.20% | 11.40% | 14.00% | 7.10% | 19.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.75% | 5.12% | 4.50% | 4.47% | 2.95% | 5.81% |
FCF Yield | 0.68% | -2.85% | -3.51% | 0.09% | -9.66% | -6.04% |
Dividend Yield | 0.22% | 0.59% | 0.42% | - | - | - |
Payout Ratio | 5.81% | 11.44% | - | - | - | - |
Buyback Yield / Dilution | 2.36% | -2.37% | -4.71% | -1.79% | 3.39% | -15.24% |
Total Shareholder Return | 2.58% | -1.78% | -4.29% | -1.79% | 3.39% | -15.24% |